Arecor Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 43

Employees

  • Stock Symbol
  • AREC

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.74
  • (As of Friday Closing)

Arecor Therapeutics General Information

Description

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.

Contact Information

Website
www.arecor.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
LON
Corporate Office
  • Chesterford Research Park
  • Little Chesterford CB10 1XL
  • England, United Kingdom
+44 01223 000000

Arecor Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arecor Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.74 $1.74 $1.70 - $3.89 $53.2M 30.6M 7.62K -$0.37

Arecor Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 73,696 72,150 120,019
Revenue 4,064 2,962 1,592 2,177
EBITDA (11,785) (12,675) (9,286) (4,185)
Net Income (11,331) (11,413) (8,483) (3,528)
Total Assets 25,389 26,340 28,236 5,838
Total Debt 211 349 312 2,719
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arecor Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arecor Therapeutics‘s full profile, request access.

Request a free trial

Arecor Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Arecor Therapeutics‘s full profile, request access.

Request a free trial

Arecor Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing inn
Drug Discovery
Little Chesterford, United Kingdom
43 As of 2023
000.00
000000000 000.00

000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000 000000000
San Diego, CA
000 As of 0000
00000
000000000 00000

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000000000000
Wayne, PA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arecor Therapeutics Competitors (71)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Crinetics Pharmaceuticals Formerly VC-backed San Diego, CA 000 00000 000000000 00000
Aclaris Therapeutics Formerly VC-backed Wayne, PA 00 00000 000000000 00000
Cyclenium Pharma Corporate Backed or Acquired Montreal, Canada 0 000000&0
Protagonist Therapeutics Formerly VC-backed Newark, CA 000 00000 00000000 00000
KBI BioPharma Formerly VC-backed Durham, NC 0000 0000 000000&0 0000
You’re viewing 5 of 71 competitors. Get the full list »

Arecor Therapeutics Patents

Arecor Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202316194-D0 Novel compositions Pending 23-Oct-2023
GB-202217025-D0 Novel compositions Inactive 15-Nov-2022
GB-202207345-D0 Novel composition Inactive 19-May-2022 00000000
GB-202207344-D0 Novel composition Inactive 19-May-2022 0000000000
GB-202118175-D0 Novel composition Inactive 15-Dec-2021 A61K47/10 0
To view Arecor Therapeutics’s complete patent history, request access »

Arecor Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Sarah Howell Ph.D Chief Executive Officer & Board Member
Susan Lowther Chief Financial Officer & Company Secretary
Jan Jezek Ph.D Chief Scientific Officer
Manjit Rahelu Ph.D Chief Business Officer
David Gerring Vice President of Development
You’re viewing 5 of 7 executive team members. Get the full list »

Arecor Therapeutics Board Members (11)

Name Representing Role Since
Alan Smith Ph.D Self Board Member 000 0000
Andrew Lane Unilever Ventures Board Member 000 0000
Sam Fazeli Ph.D Arecor Therapeutics Board Member 000 0000
Sarah Howell Ph.D Arecor Therapeutics Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 11 board members. Get the full list »

Arecor Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arecor Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arecor Therapeutics‘s full profile, request access.

Request a free trial

Arecor Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tetris Pharma 04-Aug-2022 0000000000 00.000 Pharmaceuticals 00000 000
To view Arecor Therapeutics’s complete acquisitions history, request access »

Arecor Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
Tetris Pharma Pharmaceuticals Marlow, United Kingdom 0000
To view Arecor Therapeutics’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »